Protagenic Therapeutics Ownership | Who Owns Protagenic Therapeutics?

Protagenic Therapeutics Ownership Summary

Protagenic Therapeutics is owned by 14.16% institutional investors, and 85.84% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.61% of its assets in Protagenic Therapeutics shares.

PTIX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Protagenic Therapeutics	14.16%	-	85.84%
Sector	Healthcare Stocks	279.19%	10.62%	-189.81%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2022	15	25.00%	611,430	2.25%	14	7.40%	6	20.00%	4	300.00%
Sep 30, 2022	12	9.09%	597,947	-1.11%	13	7.06%	5	25.00%	1	-50.00%
Jun 30, 2022	11	-8.33%	604,644	-10.29%	13	5.72%	4	-20.00%	2	-33.33%
Mar 31, 2022	12	-7.69%	673,973	-29.32%	15	2.34%	5	-28.57%	3	50.00%
Dec 31, 2021	13	8.33%	953,552	-0.13%	25	4.84%	7	-30.00%	2	100.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Extended Market Index	45.78K	0.61%	28.72K
Vanguard Institutional Extnd Mkt Idx Tr	32.00K	0.43%	-
Fidelity Nasdaq Composite Index	22.88K	0.30%	-
Fidelity Series Total Market Index	9.49K	0.13%	6.20K
NT Ext Equity Mkt Idx Fd - NL	3.14K	0.04%	-
NT Ext Equity Mkt Idx Fd - L	2.48K	0.03%	-
NT Ext Equity Mkt Idx Fd - DC - NL - T2	2.45K	0.03%	-45.00
Northern Trust Extended Eq Market Idx	2.48K	0.03%	-
SSgA U.S. Extended Market Index Class I	1.23K	0.03%	-
State St US Extended Mkt Indx NL Cl C	1.23K	0.02%	-

Insider Transactions Trends

Date	Buy	Sell
2023 Q4	1	-
2022 Q2	1	-
2006 Q4	-	1

PTIX Ownership FAQ

Who Owns Protagenic Therapeutics?

Protagenic Therapeutics shareholders are primarily institutional investors at 14.16%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Protagenic Therapeutics's industry, Biotech Stocks , is 63.96%, which Protagenic Therapeutics falls below.

Does Blackrock own Protagenic Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Protagenic Therapeutics.

Who is the top mutual fund holder of Protagenic Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Protagenic Therapeutics shares, with 0.61% of its total shares outstanding invested in 45.78K Protagenic Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools